United Therapeutics Corp (FRA:UTH)
€ 245.3 4.6 (1.91%) Market Cap: 10.88 Bil Enterprise Value: 8.92 Bil PE Ratio: 12.50 PB Ratio: 2.19 GF Score: 89/100

United Therapeutics Corp at Jefferies Healthcare Conference Transcript

Jun 09, 2022 / 03:00PM GMT
Release Date Price: €212.7 (-0.23%)
Eun Kyung Yang
Jefferies LLC, Research Division - MD & Senior Equity Research Analyst

Good morning, everyone. This is Eun Yang, a biotech analyst with Jefferies. I'm happy to host a fireside chat with the United Therapeutics. From United Therapeutics is James Edgemond, CFO; and Dewey Steadman, Head of IR.

So before we go into Q&A, Dewey is going to read us a safe harbor statement?

Dewey Steadman
United Therapeutics Corporation - Head of IR

Yes. So today's remarks by James and me will likely contain forward-looking statements, and we caution you to review the risks associated -- risks and uncertainties associated with those statements in our Forms 10-K and 10-Q.

Eun Kyung Yang
Jefferies LLC, Research Division - MD & Senior Equity Research Analyst

Okay. So instead of going -- asking you to an overview of the company, I'm just going to ask questions directly, go into it, given that we have only 25 minutes, okay?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot